Press Releases

Mathias Wiedemann will take over as president of WACKER BIOSOLUTIONS on January 1, 2025.

At this year’s COMPAMED medical technology tradeshow, WACKER will be presenting customized silicone rubber grades that set new standards with their optimized properties in terms of haptics, tensile strength and adhesion.

Wacker Chemie AG saw its sales decline in the third quarter of 2024 due to the ongoing difficult market environment.

Wacker Chemie AG is using today’s Capital Markets Day as an opportunity to confirm the growth and sustainable development goals communicated in 2022.

MinervaX ApS, a privately held Danish biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus (GBS) and Wacker Biotech, a contract development and manufacturing organization (CDMO), wholly owned subsidiary of Wacker Chemie AG, today announce a collaboration to manufacture MinervaX’s active protein ingredients of its GBS vaccine.